Studies have shown that after myocardial ischemia/infarction, activated LOX enzymes and their metabolites contribute to pathological changes such as cardiac hypertrophy, cardiomyocyte apoptosis, and fibrosis [40]. The gene discussed is LOX; the disease is myocardial ischemia.